What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Enzyme
Kenneth A. Krohn mostly deals with Positron emission tomography, Nuclear medicine, Pathology, FMISO and Hypoxia.
His work deals with themes such as Cancer, Head and neck cancer, Radiation therapy and Larynx, which intersect with Positron emission tomography.
His work carried out in the field of Nuclear medicine brings together such families of science as Internal medicine, Oncology and Glioma.
His Pathology research incorporates themes from Cancer research, Melanoma, In vitro, Biodistribution and Breast cancer.
His study looks at the relationship between FMISO and fields such as Misonidazole, as well as how they intersect with chemical problems.
Hypoxia and Magnetic resonance imaging are commonly linked in his work.
His most cited work include:
- Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients (511 citations)
- Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy (505 citations)
- Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. (419 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Nuclear medicine, Positron emission tomography, Pathology, Internal medicine and Hypoxia.
His work on Standardized uptake value, Pet imaging and Fluorodeoxyglucose as part of general Nuclear medicine study is frequently linked to In patient, bridging the gap between disciplines.
Kenneth A. Krohn has included themes like Magnetic resonance imaging, Cancer and Tumor hypoxia, Radiation therapy in his Positron emission tomography study.
Kenneth A. Krohn interconnects Cancer research and Biodistribution in the investigation of issues within Pathology.
His Internal medicine research incorporates elements of Endocrinology and Oncology.
His work in Hypoxia tackles topics such as Misonidazole which are related to areas like Radiochemistry.
He most often published in these fields:
- Nuclear medicine (23.55%)
- Positron emission tomography (19.68%)
- Pathology (18.06%)
What were the highlights of his more recent work (between 2011-2021)?
- Nuclear medicine (23.55%)
- Hypoxia (11.94%)
- Oncology (8.06%)
In recent papers he was focusing on the following fields of study:
Kenneth A. Krohn focuses on Nuclear medicine, Hypoxia, Oncology, Internal medicine and Cancer research.
Particularly relevant to Positron emission tomography is his body of work in Nuclear medicine.
His Hypoxia study incorporates themes from Misonidazole and Chemotherapy.
Kenneth A. Krohn has researched Oncology in several fields, including Cancer, Breast cancer, Clinical trial, Stage and Radiation therapy.
His study in Cancer research is interdisciplinary in nature, drawing from both A549 cell and Biochemistry, Cell growth.
As part of one scientific family, Kenneth A. Krohn deals mainly with the area of Tumor hypoxia, narrowing it down to issues related to the Pathology, and often Molecular imaging.
Between 2011 and 2021, his most popular works were:
- F-18 Fluoromisonidazole for Imaging Tumor Hypoxia: Imaging the Microenvironment for Personalized Cancer Therapy (71 citations)
- Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging (70 citations)
- A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET (68 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Enzyme
Kenneth A. Krohn mainly investigates Positron emission tomography, Cancer research, Magnetic resonance imaging, Pathology and Cell growth.
His Positron emission tomography research is multidisciplinary, relying on both Segmentation, Oncology, Internal medicine, Radiation therapy and Mixture model.
His Cancer research study combines topics from a wide range of disciplines, such as Misonidazole and Hypoxia.
Kenneth A. Krohn works in the field of Hypoxia, namely 18F-Fluoromisonidazole.
His work carried out in the field of Magnetic resonance imaging brings together such families of science as Brain positron emission tomography, Neuroimaging, Nuclear medicine and Glioma.
His studies in Pathology integrate themes in fields like Molecular imaging and Tumor hypoxia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
